Literature DB >> 6753889

Azathioprine dosage schedule and rejection episodes in renal transplant recipients.

L Lennard, C B Brown, M Fox, J L Maddocks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6753889      PMCID： PMC1427611          DOI： 10.1111/j.1365-2125.1982.tb02032.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  The cell cycle and its significance for cancer treatment.

Authors:  B T Hill; R Baserga
Journal:  Cancer Treat Rev       Date:  1975-09       Impact factor: 12.111

2.  Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.

Authors:  H E Skipper; F M Schabel; W S Wilcox
Journal:  Cancer Chemother Rep       Date:  1967-06

3.  Massive azathioprine overdose. Case report and review of the literature.

Authors:  D M Carney; C F Zukoski; D A Ogden
Journal:  Am J Med       Date:  1974-01       Impact factor: 4.965

4.  Immunosuppressive agents: the design of selective therapeutic schedules.

Authors:  M C Berenbaum
Journal:  Antibiot Chemother       Date:  1969

5.  Time of day of taking immunosuppressive agents after renal transplantation: a possible influence on graft survival.

Authors:  M S Knapp; N P Byrom; R Pownall; P Mayor
Journal:  Br Med J       Date:  1980-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.